Highlights

  • The bribe was alleged to waive phase-three clinical trial of Insulin Aspart injection
  • The said injection is an underdevelopment product of Biocon Biologic

Latest news

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

India-UK trade deal likely by May 1; Europe deal expected by year-end

India-UK trade deal likely by May 1; Europe deal expected by year-end

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

Changing Aspirations of Premium Homebuyers in NCR

Changing Aspirations of Premium Homebuyers in NCR

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

The CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, and Dinesh Dua, Director at Synergy Network India Private Limited, among others

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

Hitting out strongly against media reports alleging bribery charges favouring Biocon's unit, Kiran Mazumdar-Shaw took to Twitter to not only deny the allegations but also to shut down trolls.

Shaw took an aggressive stance to safeguard the integrity of Biocon as she reminded netizens to read and understand before spreading fake news. The founder of Biocon denied all allegations of wrong doing reported in a PTI news copy that had alleged a 4 lakh bribe was given to a drug controller to waive off a critical insulin trial.

Also read/watch| Bribe allegations on Biocon's injection unit, Joint drugs controller arrested

Citing procedure Kiran Mazumdar Shaw explained that "The product is EU approved n has conducted full trials globally. All that has been sought is an India trial waiver OK? Pls understand facts before jumping to conclusions. CDSCO provides for trial waiver for EU n US approved products."

Biocon Biologics - the unit under question has also issued a statement denying all allegations and is cooperating with CBI as all material and filings are available online with minutes of meetings as well.

ADVERTISEMENT

Up Next

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Reliance denies buying Iranian oil amid US sanctions waiver

Reliance denies buying Iranian oil amid US sanctions waiver

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

Govt announces seven measures to help boost exports

Govt announces seven measures to help boost exports

ADVERTISEMENT

editorji-whatsApp

More videos

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

Explained: India-US trade deal, tariffs and trade benefits

Explained: India-US trade deal, tariffs and trade benefits

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.